"While we treat all types of cancers in Sugar Land, the faculty here has particular expertise in the diagnosis, treatment and management of the following cancers: Breast Colorectal Dermatology and skin Endocrine Genitourinary Gynecologic Head and neck Neurologic Thoracic Sugar Land also offers the following treatment support services: On-site outpatient lab services Rehabilitation therapy Cancer pain management Social work Access to clinical trials Clinical nutrition Genetic counseling Plastics and reconstructive surgery Oncology nurse navigator services If you have been diagnosed with cancer, we’re here to help. Appointments are readily available and patients are cared for in an easily accessible location with free parking."

During the past decade, MD Anderson in Sugar Land conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 16 clinical trials were completed, i.e. on average, 27.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 16 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson in Sugar Land" #1 sponsor was "M.D. Anderson Cancer Center" with 31 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson in Sugar Land" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson in Sugar Land" are "Invasive Breast Carcinoma" (7 trials), "Primary Peritoneal Serous Adenocarcinoma" (6 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (5 trials), "Fallopian Tube Serous Adenocarcinoma" (5 trials) and "Ovarian Clear Cell Adenocarcinoma" (5 trials). Many other conditions were trialed in "MD Anderson in Sugar Land" in a lesser frequency.

Most popular intervention types in "MD Anderson in Sugar Land" are "Other" (61 trials), "Drug" (55 trials), "Procedure" (26 trials), "Radiation" (26 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (25 trials), "Questionnaire Administration" (19 trials), "Carboplatin" (14 trials) and "Paclitaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson in Sugar Land" are 45 trials for "All" genders, 26 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson in Sugar Land". undefined are not yet recruiting, 29 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in MD Anderson in Sugar Land, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson in Sugar Land, 5 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".